Evidence map›Paper›PMID 39831966›Full record

ReviewApplied microbiology and biotechnology2025

New approaches to secondary metabolite discovery from anaerobic gut microbes.

Lazarina V Butkovich, Oliver B Vining, Michelle A O'Malley

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lazarina V ButkovichDepartment of Chemical Engineering, University of California, Santa Barbara, CA, 93106, USA.
Oliver B ViningInstitute for Collaborative Biotechnologies, University of California, Santa Barbara, CA, 93106, USA.
Michelle A O'MalleyDepartment of Chemical Engineering, University of California, Santa Barbara, CA, 93106, USA. momalley@ucsb.edu.ORCID http://orcid.org/0000-0002-6065-8491

Funding

Biological and Environmental Research DE-AC02-05CH11231Biological and Environmental Research DE-SC0020420Biological and Environmental Research DE-SC0022142Directorate for Biological Sciences DBI - 2400327Institute for Collaborative Biotechnologies W911NF-19-1-0010Institute for Collaborative Biotechnologies W911NF-19-2-0026
6 · The paper itself

Abstract

The animal gut microbiome is a complex system of diverse, predominantly anaerobic microbiota with secondary metabolite potential. These metabolites likely play roles in shaping microbial community membership and influencing animal host health. As such, novel secondary metabolites from gut microbes hold significant biotechnological and therapeutic interest. Despite their potential, gut microbes are largely untapped for secondary metabolites, with gut fungi and obligate anaerobes being particularly under-explored. To advance understanding of these metabolites, culture-based and (meta)genome-based approaches are essential. Culture-based approaches enable isolation, cultivation, and direct study of gut microbes, and (meta)genome-based approaches utilize in silico tools to mine biosynthetic gene clusters (BGCs) from microbes that have not yet been successfully cultured. In this mini-review, we highlight recent innovations in this area, including anaerobic biofoundries like ExFAB, the NSF BioFoundry for Extreme & Exceptional Fungi, Archaea, and Bacteria. These facilities enable high-throughput workflows to study oxygen-sensitive microbes and biosynthetic machinery. Such recent advances promise to improve our understanding of the gut microbiome and its secondary metabolism. KEY POINTS: • Gut microbial secondary metabolites have therapeutic and biotechnological potential • Culture- and (meta)genome-based workflows drive gut anaerobe metabolite discovery • Anaerobic biofoundries enable high-throughput workflows for metabolite discovery.

Indexed as

Bacteria, AnaerobicGastrointestinal MicrobiomeSecondary MetabolismAnaerobiosisAnimalsArchaeaBacteriaBiotechnologyFungiAnaerobicBiofoundryGenome miningGut microbiomeSecondary metabolite

Identifiers

PMID39831966
PMCPMC11747023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.